trending Market Intelligence /marketintelligence/en/news-insights/trending/__pqtxhtvdoweudwqq4_rq2 content esgSubNav
In This List

Gilead Sciences director to retire

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Gilead Sciences director to retire

Gilead Sciences Inc. said director Nicholas Moore would retire from the board, effective as of the end of his term in May.

Moore's decision to retire was not the result of any dispute or disagreement with the company.